Results 91 to 100 of about 47,590 (163)

<i>In vitro</i> activity of cefepime/zidebactam against <i>Klebsiella pneumoniae</i> carrying <i>bla</i> _KPC variants conferring resistance to ceftazidime/avibactam. [PDF]

JAC Antimicrob Resist
Tascini C, Marshall SH, Bonomo RA, Gaibani P.   +3 more
europepmc   +1 more source

Corrigendum: Reactive Oxygen Species-Related Ceftazidime Resistance Is Caused by the Pyruvate Cycle Perturbation and Reverted by Fe3+ in Edwardsiella tarda

Frontiers in Microbiology, 2021
Jinzhou Ye, Yubin Su, Xuanxian Peng, Xuanxian Peng, Hui Li, Hui Li   +5 more
doaj   +1 more source

High-dose aztreonam potentiates the combined antimicrobial activity of ceftazidime-avibactam against extensively drug-resistant New Delhi metallo-β-lactamase positive <i>Pseudomonas aeruginosa</i> in severe pneumonia treatment: the first global case report. [PDF]

Front Cell Infect Microbiol
Liu Y, Mo C, Li M.
europepmc   +1 more source

<i>In vivo</i> selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing <i>E. coli</i> ST410. [PDF]

Antimicrob Agents Chemother
Jousset AB, Girlich D, Oueslati S, Birer A, Delaval A, Guyot C, Rezzoug I, Emeraud C, Naas T, Bonnin RA, Dortet L.   +10 more
europepmc   +1 more source

<i>Delftia</i> spp as Opportunistic Pathogens: a narrative review. [PDF]

New Microbes New Infect
Ryan MP, Tony Pembroke J.
europepmc   +1 more source

Treatment Bundle for Bloodstream Infection Caused by Carbapenem-Resistant <i>Klebsiella Pneumoniae</i> After Liver Transplantation: A Retrospective Cohort Study. [PDF]

Infect Drug Resist
Guo Z, Wu G, Hou Y, Zhao H, Li A, Hao H, Lin J, Tong X, Lu Q, Tang R.   +9 more
europepmc   +1 more source

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database. [PDF]

Pharmaceuticals (Basel)
Arseniu AM, Vintila BI, Butuca A, Stoicescu L, Frum A, Chis AA, Arseniu R, Gligor FG, Ghibu S, Morgovan C, Dobrea CM.   +10 more
europepmc   +1 more source

The impact of ceftazidime-avibactam on 30-day mortality in the treatment of OXA-48 producing <i>Enterobacterales</i> infections: a systematic review and meta-analysis. [PDF]

JAC Antimicrob Resist
Foo AL, Young B, Ng OT, Vasoo S.
europepmc   +1 more source

Analysis of a simple disk diffusion method to evaluate ceftazidime-avibactam/aztreonam combination synergism against New Delhi metallo-beta-lactamase-producing clinical isolates. [PDF]

Access Microbiol
Rajan R, Gopinathan S, Rao AVR, B R, Mathavi S.   +4 more
europepmc   +1 more source

Ceftazidime prescription and antibiotic resistance patterns in a tertiary care hospital. [PDF]

Sci Rep
Aiesh BM, Amoudi S, Bassalat L, Yousef A, Abuhalima D, Abutaha A, Al-Jabi SW, Sabateen A, Zyoud SH.   +8 more
europepmc   +1 more source